ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

GRCL Gracell Biotechnologies Inc

10,25
0,00 (0,00%)
10 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Gracell Biotechnologies Inc GRCL NASDAQ Depository Receipt
  Änderung Änderung % Aktuell Zeit
0,00 0,00% 10,25 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
10,25 10,25
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
04.3.202418:22EDGAR2Form 15-12G - Securities registration termination [Section..
28.2.202406:15EDGAR2Form EFFECT - Notice of Effectiveness
26.2.202423:28EDGAR2Form S-8 POS - Securities to be offered to employees in..
26.2.202423:28EDGAR2Form POS AM - Post-Effective amendments for registration..
26.2.202423:26EDGAR2Form POS AM - Post-Effective amendments for registration..
26.2.202423:26EDGAR2Form S-8 POS - Securities to be offered to employees in..
22.2.202414:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22.2.202414:45GLOBEGracell Biotechnologies Acquisition Completed
20.2.202414:22EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20.2.202413:45GLOBEGracell Biotechnologies Announces Shareholders’ Approval of..
14.2.202414:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
30.1.202412:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29.1.202413:00GLOBEGracell Biotechnologies Announces FDA Clearance of IND..
17.1.202422:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08.1.202422:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08.1.202416:06PRNUSKuehn Law Encourages KRTX, DSKE, RYZB, and GRCL Investors to..
26.12.202314:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26.12.202312:44DJNGracell ADSs Take Flight Premarket on $1.2 Billion Takeover..
26.12.202309:05DJNAstraZeneca to Buy Gracell Biotechnologies for $1.2 Billion
26.12.202308:01BWAstraZeneca to acquire Gracell, furthering cell therapy..
26.12.202308:00GLOBEGracell Biotechnologies to be acquired by AstraZeneca,..
22.12.202312:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21.12.202313:00GLOBEGracell Biotechnologies Announces China NMPA Clearance for..
18.12.202322:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12.12.202301:30GLOBEGracell Biotechnologies Presents Updated Clinical Data from..
29.11.202312:18IHMARKETNEWSAmazon Unveils Innovative Services, Okta Discloses Data..
28.11.202320:59DJNCabaletta Bio Down as FDA Looks Into Issues With Several..
27.11.202314:00GLOBEGracell Biotechnologies Announces FDA Clearance of IND..
21.11.202312:25EDGAR2Form 144 - Report of proposed sale of securities
16.11.202314:00GLOBEGracell Biotechnologies to Participate in Inaugural Cell..
14.11.202312:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13.11.202313:30GLOBEGracell Biotechnologies Reports Third Quarter 2023 Unaudited..
08.11.202314:30GLOBEGracell Biotechnologies Wins Overall Immunology Solution of..
02.11.202314:00GLOBEGracell Biotechnologies to Present Updated Results from..
01.11.202321:00GLOBEGracell Biotechnologies to Participate in Four Upcoming..
31.10.202314:00GLOBEGracell Biotechnologies to Present Data Highlighting..
30.10.202313:30GLOBEGracell Biotechnologies to Report Third Quarter 2023..
29.9.202312:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27.9.202314:30GLOBEGracell Biotechnologies Reports Updated Clinical Data for..
27.9.202312:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26.9.202322:00GLOBEGracell Biotechnologies Doses First Patient in Phase 1b/2..
19.9.202315:21GLOBEGracell Biotechnologies’ CEO Dr. William Cao Named to..
14.9.202315:15GLOBEGracell Biotechnologies to Participate in Three Upcoming..
12.9.202322:12EDGAR2Form F-3/A - Registration statement by foreign private..
06.9.202314:00PRNUSGracell Biotechnologies to Present Updated Clinical Data on..
24.8.202322:10GLOBEGracell Biotechnologies to Participate in Two Upcoming..
24.8.202322:03EDGAR2Form F-3 - Registration statement by foreign private issuers
23.8.202312:47EDGAR2Form 144 - Report of proposed sale of securities
18.8.202322:56EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14.8.202322:52EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..